Riluzole is the first drug to be approved for amyotrophic lateral sclerosis (ALS). Riluzole, available as RilutekĀ®, does not cure ALS or improve symptoms, but may extend survival or the time to tracheostomy.
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 24, 2009.